UnitedHealth Group plans to rebate any profits from its ACA plans in 2026 due to potential changes in premium tax credits. The stock price of UNH has been volatile but recently showed a 6% increase. Despite political noise, UnitedHealth beat earnings estimates in Q3 2025 with $113.2 billion in revenue. Analysts have a “Moderate Buy” rating on UNH with a mean target price of $396.61, indicating a potential gain of 15%. The company’s diversification in Medicare Advantage and Optum’s services network mitigate the impact of rebating ACA margins on overall profits.

Read more at Barchart: UnitedHealth Announces Plans to Rebate ACA Profits. What Does That Mean for UNH Stock as Trump Takes Aim at Insurers?